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While Trk receptors can be activated in a neurotrophin-independent manner through ‘‘transactivation’’ by
GPCR ligands, its physiological significance in the brain remains unknown. Huang et al. have now identified
a novel mechanism of TrkB transactivation. They show that zinc ions can transactivate TrkB independent of
neurotrophins and that such a transactivation is important for mossy fiber long-term potentiation (LTP).A dogma in the neurotrophin field, and
indeed in cell signaling in general, is that
neurotrophins signal by binding their cog-
nate Trk receptors at the cell surface.
Ligand binding initiates Trk receptor di-
merization and phosphorylation via its
intrinsic tyrosine kinase. Phosphorylated
intracellular cytoplasmic tails of Trk act
as docking sites for adaptor molecules,
which in turn activate any/all of the three
major downstream signaling pathways
(Ras/MAPK/Erk, PI3K/Akt, and PLC-g)
to regulate neuronal survival, neurite
outgrowth and branching, and synaptic
transmission and plasticity (Huang and
Reichardt, 2003). Until recently, Trk re-
ceptors were believed to be activated
solely by neurotrophins. For example,
TrkB is activated by either brain-derived
neurotrophic factor (BDNF) or neurotro-
phin 4 (NT4). A neurotrophin-independent
mechanism for TrkB activation was impli-
cated by the observation that neither
a null mutation of NT4 nor a conditional
deletion of BDNF prevented TrkB activa-tion during epileptogenesis (He et al.,
2006, 2004). Intriguing studies by Lee
et al. (Lee and Chao, 2001; Lee et al.,
2002) provided evidence that, at least
in cell culture, Trk signaling can occur
independently of direct ligand/neurotro-
phin binding through ‘‘transactivation’’
by G protein-coupled receptor (GPCR)
ligands such as adenosine or the neuro-
peptide PACAP. As the term suggests,
transactivation refers to ligand-indepen-
dent, indirect activation of receptor sig-
naling. Further studies demonstrated
that Trk receptors are activated intracellu-
larly through Src kinase-mediated tyro-
sine phosphorylation. However, it was un-
clear whethermolecules other thanGPCR
ligands can transactivate Trks. Moreover,
the physiological significance of Trk re-
ceptor transactivation in the brain in vivo
was also difficult to ascertain. The study
by Huang et al. published in this issue of
Neuron represents a major leap forward:
the divalent cation zinc released in the
hippocampal CA3 area in response toNeuron 57neural activity not only transactivates
TrkB in vivo, but this transactivation plays
a significant role in long-term potentiation
(LTP) at the mossy fiber (MF)-CA3 synap-
ses (Huang et al., 2008).
Previous studies have suggested that
zinc (and copper) can activate TrkB
by converting proBDNF to mature BDNF
(mBDNF) through extracellular metallo-
proteinases (Hwang et al., 2005, 2007). In
the present study, Huang et al. performed
a series of experiments to show that zinc
can directly activate TrkB in the absence
of BDNF. First, zinc, but not other divalent
or monovalent cations (Mg2+, Ca2+, K+,
Na+, etc.), selectively activates TrkB (not
TrkA or TrkC) and its downstream signal-
ing pathways (Erk1/2, CREB, and PLC-g).
Second, zinc transactivates TrkB not only
in wild-type (+/+) neurons when extracel-
lular BDNF has been removed by the
scavenger TrkB-IgG, but also in neurons
derived from BDNF null mutant (/) or
in TrkB-expressing heterologous cells.
Third, zinc-induced TrkB activation was, February 28, 2008 ª2008 Elsevier Inc. 477
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PreviewsFigure 1. Schematic Illustration of BDNF-Dependent and -Independent Mechanisms of TrkB
Activation
Classical sequence of TrkB activation entails BDNF binding to cell surface TrkB, followed by receptor di-
merization, autophosphorylation (minutes), and finally activation of the downstream signaling pathways
(ERK/MAPK, PI3K, PLCg). In contrast, GPCR ligands (adenosine, PACAP) indirectly transactivate both
cell surface and intracellularly localized Trk receptors (hours) through Src kinase. A newly identifiedmech-
anism of TrkB transactivation involves zinc. Neuronal activity, i.e., LTP inducing stimuli, induces the re-
lease of zinc along with glutamate from mossy fiber terminals. Entering the postsynaptic neuron through
NMDAR or VDCC, zinc activates Src kinase to phosphorylate and transactivate TrkB (minutes) by inhibit-
ing CSK kinase.abolishedby theTrk kinase inhibitor k252a
and the extracellular zinc chelator Ca2+-
EDTA, but activated by the zinc iono-
phore, sodium pyrithione. Finally, zinc
does not occlude or display synergism
with BDNF-induced TrkB activation, sug-
gesting zinc-induced TrkB transactivation
operates by a mechanism distinct from
BDNF-induced activation. Using pharma-
cological approaches, Huang et al. also
showed that zinc enterspostsynaptic neu-
rons through voltage-gated calciumchan-
nels (VGCCs) and NMDA receptors, but
not through AMPA receptors. Following
its entry, zinc activates Src family kinase
(SFK) (Src, Yes, and Fyn) by relieving their
autoinhibition. Src kinase, in turn, transac-
tivates TrkB by phosphorylation, leading
to its activation.
An important contribution of the present
study is to identify zinc as a new form of
Trk transactivation, which is very different
from that of GPCR ligands (Figure 1). First,
while TrkB transactivation by extracellular478 Neuron 57, February 28, 2008 ª2008 Elligands like adenosine and PACAP require
cell surface GPCRs and Ca2+ influx, zinc
enters postsynaptic neurons and transac-
tivates TrkB intracellularly by inhibiting
C-terminal Src kinase (CSK). Bothmecha-
nisms require Src to activate TrkB. Sec-
ond, unlike GPCR ligands, which activate
only PLC-g and PI3 kinase/Akt pathways,
zinc activates all the three major signaling
pathways. Third, zinc transactivates TrkB
more potently and much faster (minutes)
than GPCR ligands (hours). Fourth, while
zinc transactivates only full-length TrkB
receptors localized to the postsynaptic
density of excitatory synapses, GPCR
ligands activate both surface localized
mature Trk receptors and intracellularly lo-
calized immature Trk receptors (Figure 1).
Finally, endogenous zinc stored in secre-
tory vesicles is released at CA3 synapses
in response to neuronal activity. Whether
endogenous GPCR ligands are also re-
leased right at excitatory synapses in an
activity-dependent manner is unclear.sevier Inc.TrkB transactivation by endogenous
cannabinoids (throughcannabinoid recep-
tor 1, CB1R) regulates the migration and
morphogenesis of cholecystokinein-posi-
tive cortical interneurons during develop-
ment (Berghuis et al., 2005). What is the
physiological significance of TrkB transac-
tivation by zinc (independent of BDNF)
in the hippocampus? Zinc is enriched
in synaptic vesicles through specialized
zinc transporters at the MF-terminals and
released along with glutamate in a Ca2+-
dependent manner. Several studies have
proposed a modulatory role for zinc in
excitatory neurotransmission. Zinc influx
into CA3 neurons through glutamate re-
ceptors has been shown to elicit a long-
lasting synaptic potentiation in hippocam-
pal slices (Li et al., 2001). Huang et al.
show that zinc-induced potentiation was
abolished in hippocampal slices from
TrkB/ or drug-inducible TrkB mutants
(TrkBF616A), suggesting a requirement for
TrkB tyrosine kinase. Interestingly, zinc-in-
duced synaptic potentiation still occurred
in BDNF/ slices. Thus, zinc-mediated
potentiation at MF-CA3 synapses is due
toTrkB transactivation rather thanconven-
tional BDNF-TrkB signaling.
To examine the physiological relevance
of zinc-induced TrkB transactivation, the
authors studied LTP induced by high-
frequency stimulation (HFS). While it is
believed that MF-CA3 LTP is NMDA
receptor-independent and is expressed
presynaptically (Nicoll and Schmitz,
2005), results from this study favor a post-
synaptic mechanism for zinc/TrkB-medi-
ated LTP. Like zinc-induced potentiation,
HFS elicited robust LTP at MF-CA3 syn-
apses in wild-type hippocampal slices,
but not in slices from TrkB/ or drug-
inducible TrkBF616A mutants. Moreover,
removing extracellular zinc with the zinc
chelator Ca2+-EDTA completely abol-
ished HFS-induced LTP. The magnitude
of LTP was only slightly reduced in
BDNF/ slices. The control Schaeffer
collateral-CA1 LTP remained unaltered
in the TrkB mutant when the same HFS
was applied. Taken together, these re-
sults support a model in which high-
frequency neuronal activity drives secre-
tion of zinc, which in turn transactivates
TrkB independently of BDNF to facilitate
CA3 LTP (Figure 1). This novel mecha-
nism may be operative in conjunction
with the conventional, BDNF-dependent
Neuron
Previewsmechanism to regulate the function of
mossy fiber synapses.
The finding by Huang et al. provides
new insights into the molecular mecha-
nisms of MF-CA3 LTP, a process impli-
cated in the storage and recall of informa-
tion and pattern completion. A major
function of zinc released at CA3 is to
transactivate TrkB, which may facilitate
mossy fiber LTP. Moreover, transactiva-
tion of TrkB by zinc may also have impli-
cations for our understanding of epilepsy
etiology. The morphological and physio-
logical changes that occur during limbic
epileptogenesis (induced by kindling)
in vivo closely resemble that of HFS-
induced LTP at MF-CA3 synapses (Gous-
sakov et al., 2000). In fact, deletion of TrkB
prevented epileptogenesis in the kindling
model (He et al., 2004). Therefore, zinc-
mediated TrkB transactivation may con-
tribute to the underlying cellular mecha-
nisms recruited during epileptogenesis.
The study by Huang et al. strongly
supports a BDNF-independent mecha-
nism of zinc-induced TrkB activation.
However, several biochemical experi-
ments performed under similar conditions
have yielded contradictory results that are
hard to reconcile (Hwang et al., 2005). For
instance, in the current study the zinc ion-
ophore sodium pyrithione was able to en-
hance zinc-induced TrkB transactivation,
while under almost identical conditions
it had no effect in the previous study. Che-
lating zinc by Ca2+-EDTA here completely
eliminated the zinc effect, whereas theprevious experiment using BAPTA-AM
failed to block zinc-induced TrkB phos-
phorylation. An anti-BDNF antibody in-
hibited TrkB activation in the earlier study.
In contrast, Huang et al. now show that
TrkB transactivation still occurs in neu-
rons treated with TrkB-IgG or in those
derived from BDNF/ mice. Further
experiments using BDNF/NT4 double-
knockout mice should exclude the possi-
bility of NT4-dependent TrkB activation in
the absence of BDNF. These results argue
for two completely different mechanisms
for zinc-mediated TrkB activation. It is
difficult to imagine how the BDNF neutral-
izing antibodies and matrix metalloprotei-
nase inhibitors used in the previous study
could abolish zinc-induced TrkB transac-
tivation by a BDNF-independent mecha-
nism, which is proposed in this study.
Further studies are necessary to resolve
these discrepancies.
While the results from this study unveil
a novel mechanism of TrkB transactiva-
tion and its downstream signaling, they
also raise several important questions,
which should be addressed by future re-
search (Figure 1). For example, how does
neuronal activity govern zinc entry to
regulate CSK activity? Does zinc inhibit
CSK directly or indirectly? How does Src
specifically regulate TrkB (not Trk C or A)
activation? Since both zinc and BDNF ac-
tivate TrkB in similar manners, are there
differences in their biological outcomes?
If not, why has nature evolved two similar,
if not identical, mechanisms to governNeuron 5TrkB activation? Based on the new find-
ings, it is tempting to propose zinc as
a therapeutic agent for neurodegenerative
disorders, since it does not have the usual
problemsof stability andCNSdelivery that
are associatedwith neurotrophin proteins.
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